Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Ordinary shares, nominal value $0.025 per share
-
Shares outstanding
-
61.7M
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
32.6M
-
Shares change
-
+499K
-
Total reported value, excl. options
-
$325M
-
Value change
-
+$3.72M
-
Number of buys
-
17
-
Number of sells
-
-10
-
Price
-
$9.98
Significant Holders of GH Research PLC - Ordinary shares, nominal value $0.025 per share (GHRS) as of Q2 2022
36 filings reported holding GHRS - GH Research PLC - Ordinary shares, nominal value $0.025 per share as of Q2 2022.
GH Research PLC - Ordinary shares, nominal value $0.025 per share (GHRS) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.6M shares
of 61.7M outstanding shares and own 52.73% of the company stock.
Largest 10 shareholders include BVF INC/IL (9.28M shares), FMR LLC (4.94M shares), RA CAPITAL MANAGEMENT, L.P. (4.9M shares), VR Adviser, LLC (3.19M shares), RTW INVESTMENTS, LP (2.17M shares), ORBIMED ADVISORS LLC (1.62M shares), CITADEL ADVISORS LLC (1.3M shares), BOXER CAPITAL, LLC (1.01M shares), Verition Fund Management LLC (608K shares), and Cormorant Asset Management, LP (608K shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.